Liraglutide Market: Major Trends Reshaping the Future of the Industry

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Liraglutide Industry Market Size Be by 2025?
In the past few years, the liraglutide market has witnessed a robust expansion. The market size is predicted to surge from $6.38 billion in 2024 to $6.88 billion in 2025, marking a compound annual growth rate (CAGR) of 7.9%. Factors driving growth during the historic period encompass an uptick in diagnosed type 2 diabetes cases, escalating obesity rates, numerous clinical trials, improved awareness of diabetes-related complications, and breakthroughs in drug delivery systems.

What's the Long-Term Growth Forecast for the Liraglutide Market Size Through 2029?
Over the ensuing years, the liraglutide market is projected to experience robust expansion, reaching $9.45 billion by 2029 with an 8.3% CAGR. Factors causing this anticipated growth in the forecasted timeframe include the expansion of insurance and reimbursement policies, healthcare infrastructure enhancement, increased awareness initiatives and education, an upsurge in the elderly population, and a enlarging prevalence of diabetes. The forecast period also foresees major trends such as the adoption of artificial intelligence and machine learning, the demand for wearable technologies, the integration of continuous glucose monitoring, advancements in biotechnology, and the creation of digital health platforms.

View the full report here:
https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

What Are the Key Growth Drivers Fueling the Liraglutide Market Expansion?
The liraglutide market is anticipated to see exponential growth as a result of the growing population suffering from diabetes. Diabetes, a chronic disease wherein the body is unable to control blood sugar levels due either to insufficient production of insulin or its ineffective use, is on the rise. The reason for this increase is factors such as inactive lifestyles, unhealthy food habits, and escalating obesity rates all over the globe. Medications like liraglutide are beneficial as they simulate the function of the GLP-1 hormone, which improves insulin secretion, reduces blood sugar levels, and facilitates weight loss, thereby assisting in managing type 2 diabetes. For instance, a report published by the UK Government in March 2024 showed that the number of people with type 1 diabetes in England who received a complete set of 8 care processes at GP stations involved in the NDA was 43.8% in March 2023, a substantial increase from the previous year's figure of 35.2%. As a result of these facts, the escalating diabetic population is fueling the growth of the liraglutide market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18659&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Liraglutide Market?
Major firms in the liraglutide market are innovating and launching new products like generic GLP-1 to cater to the need for more economical options and broaden the spectrum of treatments. The term 'generic GLP-1' pertains to GLP-1 receptor agonists that are manufactured after the patents on the original branded medications have expired, providing a cost-effective route to treat conditions such as type 2 diabetes and obesity. For example, in June 2024, Teva Pharmaceutical Industries Ltd., a pharmaceutical corporation based in Israel, launched the first generic GLP-1, similar to Victoza, in the American market, fulfilling the growing need for these treatments. Liraglutide injections are recommended for improving blood sugar control in adults and children 10 years and older who have type 2 diabetes, and in reducing the risk of cardiovascular events in adults with type 2 diabetes and pre-existing cardiovascular diseases.

How Is the Liraglutide Market Segmented?
The liraglutide market covered in this report is segmented -

1) By Brands: Victoza, Saxenda
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Drug Stores, Online Pharmacies
3) By Type Of Application: Diabetes Treatment, Weight Management
4) By End-Users: Hospitals And Clinics, Homecare Settings

Subsegments:
1) By Victoza: Type 2 Diabetes Treatment Or Weight Management
2) By Saxenda: Weight Loss Treatment Or Obesity Management

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18659&type=smp

Which Companies Are Leading the Charge in Liraglutide Market Innovation?
Major companies operating in the liraglutide market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Biocon Limited, Hanmi Pharmaceutical Co. Ltd., Intarcia Therapeutics Inc., Adocia SA

Which Regions Are Leading the Global Liraglutide Market in Revenue?
North America was the largest region in the liraglutide market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the liraglutide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18659

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.